Meningioma 1 (MN1) was identified as a gene disrupted by a balanced translocation in meningioma 32. Functionally, MN1 is a transcriptional co-activator and can stimulate the expression of IGFBP5, DHRS9, and other genes that play a role in hematopoiesis and leukemogenesis.
Alternative names for
MN1 Antibody include
Probable tumor suppressor protein
meningiomadisrupted in balanced translocation) 1 antibody,
probable tumor suppressor protein
meningioma chromosome region 1 antibody,
meningiomatranslocation balanced) antibody.